Overview

The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)

Status:
Terminated
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Patients with stable coronary artery disease, undergoing PCI by means of implantation of >33 mm of DES, will be randomized single-blinded to eptifibatide plus unfractioned heparin according to the ESPRIT protocol vs placebo plus unfractioned heparin.
Phase:
Phase 4
Details
Lead Sponsor:
University of Turin, Italy
Treatments:
Eptifibatide